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Abstract
Background: Caesarean section (CS) has become an increasingly common method of delivery worldwide, rising
in the UK from 9% of deliveries in 1980 to over 21% 2001. This increase, and the question of whether CS should
be available to women on request, has been the subject of considerable debate, and national reports and
guidelines have specifically highlighted the importance of patient choice in the decision making process. For
women who have already experienced CS, the UK National Institute of Clinical Excellence recommends that the
decision should consider maternal preferences and priorities in addition to general discussion of the overall risks
and benefits of CS. Decision aids for many different medical treatment and screening decisions have been
developed and evaluated, but there is relatively little evidence for the use of decision aids for choice of mode of
delivery among women with a previous CS. The aim of the study is to evaluate two interventions to assist decision
making about mode of delivery among pregnant women with one previous CS.
Methods/design: Women with one previous CS are recruited to the trial during their booking visit at
approximately 12–20 weeks' gestation in participating maternity units in Bristol, Weston and Dundee. Using
central randomisation, women are allocated to one of three arms: information programme and website; decision
analysis; usual care. Both interventions are computer-based, and are designed to provide women with detailed
information about the potential outcomes for both mother and baby of planned vaginal delivery, planned CS and
emergency CS. The decision analysis intervention additionally provides a recommended 'preferred option' based
on maximised expected utility. There are two primary outcomes (decisional conflict and actual mode of delivery),
and five secondary outcomes (anxiety, knowledge, perceptions of shared decision making; satisfaction with
decision making process, proportion of women attempting vaginal delivery). Primary follow up for the
questionnaire measures is at 36–37 weeks' gestation, and a total of 660 women will be recruited to the study.
The primary intention-to-treat analyses will comprise three pair-wise comparisons between decision analysis,
information and usual care groups, for each of the two primary outcomes. A qualitative study will investigate
women's experiences of the decision making in more depth, and an economic evaluation from the perspective of
the NHS will be conducted.
Discussion: Provision of information to women facing this decision appears variable. The DiAMOND study aims
to inform best practice in this area by evaluating the effectiveness of two interventions designed to aid decision
making.
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Background
Over the last 20 years caesarean section (CS) has become
an increasingly common method of delivery. The CS rate
in the United Kingdom rose from 9% of deliveries in 1980
to 21% in 2001 [1]. This increase, and the question of
whether CS should be available to women on request, has
been the subject of considerable debate [2]. The optimal
mode of delivery for women who have experienced a pre-
vious CS is complicated by the difficulty in balancing the
risks of repeat CS with those of vaginal birth after caesar-
ean section (VBAC). An evaluation of caesarean delivery
by the American College of Obstetricians and Gynecolo-
gists reported that first time mothers with term singleton
cephalic pregnancies and women with a previous CS
account for two thirds of all caesarean deliveries in the US
[3].
The Changing Childbirth report has emphasised the
importance of patient choice when decisions need to be
made in relation to the management of pregnancy and
childbirth [4]. However the views of women who have
experienced CS and their preferences for future deliveries
have received little attention to date. Obstetricians tend to
focus on the risks of uterine rupture and emergency cae-
sarean section in labour [5], which may influence the
advice they give to women uncertain about future mode
of delivery. Others have focused on the increased morbid-
ity following CS [6] and on the negative impact of opera-
tive delivery on first postnatal contact between the mother
and her baby [7]. In Chile, where there is a very high rate
of CS in the private sector, only a minority of women
reported that they had wanted this method of delivery [8].
In a Scottish study, more women who delivered by elec-
tive CS reported they were satisfied with their involve-
ment in the decision making process compared with
women who underwent emergency CS [9]. The advan-
tages and disadvantages of planned CS versus planned
vaginal delivery has also been debated in north America in
response to a growing number of requests for elective CS
[10].
In an attempt to ensure appropriateness of CS in the UK,
a set of evidence-based guidelines on indications for CS
have recently been published [11]. The guidelines, com-
missioned by the UK National Institute for Clinical Excel-
lence, make a specific recommendation that for women
with a previous CS, the decision should consider maternal
preferences and priorities in addition to general discus-
sion of the overall risks and benefits of CS. It is essential
that the process of decision making about future mode of
delivery is evaluated and enhanced to achieve the safest
and most satisfactory outcome for both mother and baby.
It has been proposed that the way in which clinical deci-
sions are made lies on a continuum, from paternalistic
(clinician decides) through partnership (clinician and
patient share the decision) to informed (patient decides)
[12]. Although proposed as the preferred approach of
determining patients' treatments [13], some problems
with the concepts, terminology and practice of shared
medical decision making have recently been highlighted
[14]. The appropriateness of the shared model may also
depend on the clinical context as well as patients' and cli-
nicians' preferences for involvement in decision making
[15]. In addition, there is some evidence that patients and
health professionals often have different treatment prefer-
ences, potentially making agreement on a treatment strat-
egy more difficult [16].
Decision aids are designed to help people select between
various treatment strategies by providing information on
the options and outcomes relevant to a person's health.
Decision aids for many clinical conditions have been
developed [17], and evaluations of these decision aids
have been the subject of systematic reviews [18,19]. A
north American trial found no difference in terms of
VBAC rate between written versus personal counselling
interventions that actively promoted vaginal delivery [20].
An Australian trial of a paper-based decision aid for
women who have previously experienced CS is currently
underway [21].
The specific content of decision aids may vary, but in gen-
eral they aim to present more than one strategy for clinical
management, help people understand the probable out-
comes of treatment choices and allow people to consider
the personal value they place on benefits versus harms.
Decision aids can take several formats, such as leaflets,
interactive videodisks, individualised decision analysis,
personal counselling sessions and audio workbooks.
Interventions to assist patient decision making can
improve knowledge about treatment options, make
patients more realistic in their expectations, reduce deci-
sional conflict and increase active involvement in decision
making [18].
As an intervention to aid patient decision making, indi-
vidualised decision analysis has so far received limited
attention. By explicitly combining patients' values regard-
ing treatment outcomes and individual probability infor-
mation, decision analysis attempts to provide a rational
framework to guide patient decision making. The use of
individualised decision analysis has been debated [22],
but empirical evidence demonstrates that it is feasible and
acceptable and has value as an aid to patient decision
making [23].
Aim
The aim of this paper is to describe the protocol for a ran-
domised controlled trial of two interventions to aid deci-
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sion making about mode of delivery among pregnant
women with one previous CS. The interventions being
assessed are (1) Decision analysis, and (2) Information
programme and website. Both decision aids will be com-
pared with usual care given by the obstetric team. The
interventions will be assessed in terms of decisional con-
flict, planned and actual mode of delivery, anxiety, knowl-
edge, perception of shared decision making and
satisfaction with the decision making process. Develop-
ment and piloting of the interventions took place in
2003–2004, and the main phase of the study started in
May 2004 and will continue until December 2006. Ethical
approval for the study was obtained from the UK South
West Multi-Centre Research Ethics Committee.
Methods/design
Recruitment and allocation of participants
The sample will comprise pregnant women with one pre-
vious lower segment CS (all parities will be included, but
the most recent delivery must have been CS), no current
obstetric problems and delivery expected at ≥ 37 weeks.
Women are being recruited to the study by research mid-
wives during their initial booking visit at approximately
12–20 weeks' gestation. Recruitment takes place from
maternity units in St Michael's and Southmead Hospitals
in Bristol, Weston General Hospital, and Ninewells Hos-
pital in Dundee. The current CS rates for these units range
between 18 and 24% and are representative of rates for
other units throughout England and Scotland. The
women are informed that although both vaginal delivery
and repeat CS carry their own benefits and risks, the best
method of presenting this information in order to assist
women in reaching a decision is not known. Women
expressing an interest in participating in the trial at the
booking visit are given an information sheet, a written
consent form and a baseline questionnaire to take home.
Following receipt of the baseline questionnaire and writ-
ten informed consent to enter the trial, women are ran-
domised to one of three arms as detailed below.
Allocation is stratified by maternity unit and preferred
mode of delivery and blocked (using random permuted
blocks of sizes 6, 9, 12 and 15) to ensure reasonable bal-
ance between the trial groups through time. The randomi-
sation sequence was generated by a member of the study
team (AAM), and allocation of participants is performed
by a staff member with no other involvement in the study.
Interventions
Both interventions are computer based. Women allocated
to receive an intervention have an appointment with a
researcher to allow the decision aid to be delivered using
a laptop computer, usually in the woman's own home or
workplace.
(i) Information programme and website
This intervention provides information about the out-
comes associated with planned vaginal delivery, planned
CS, and emergency CS. This includes descriptions of out-
comes for both mother and baby, and the probabilities of
these outcomes based on the best available evidence. Both
the probabilities of having and not having the event are
given, and all probabilities are presented in both numeri-
cal and pictorial format [24]. The programme easily
allows women to choose the information that they view,
and the information each women accesses is logged. At
the end of the initial appointment with a researcher,
women are given a password that allows them to access
the information programme via the internet as often as
they wish. Womens' use of the programme via the internet
is also logged.
(ii) Decision analysis
There are generally four main steps involved in a decision
analysis. The first is to draw up a decision tree that maps
out the likely outcomes of the strategies in question [25].
These outcomes are then assigned utilities that represent
how an individual values a particular outcome. A utility is
a number between 0 and 1, often representing the out-
comes 'death' and 'perfect health' respectively [26]. Prob-
ability information is then included in the tree to
represent the chance of each outcome occurring [26].
Finally, strategies are compared by calculating the
weighted sum of the utilities of all possible outcomes
[27]. The recommended strategy is that with the highest
expected utility value, or in other words, the one that gives
an individual the best chance of achieving an outcome
that is valued.
The decision analysis intervention in the trial proceeds
according to the principles described above. First, women
are given information about the outcomes associated with
planned vaginal delivery, planned CS, and emergency CS.
This includes descriptions of outcomes for both mother
and baby, but not the probabilities of these events. These
are embedded in the decision tree which is not visible to
users. Second, women are required to rate (assign a utility
value between 0 and 1) each possible outcome using a vis-
ual analogue scale. Finally, the programme combines the
elicited utilities and the probabilities of each outcome in
a decision tree to produce a recommended 'preferred
option' based on maximised expected utility. Each
woman is given a computer printout of the outcome of
the decision analysis.
(iii) Usual care
This comprises care normally given by the obstetric and
midwifery team. Women allocated to decision analysis or
information programme receive these interventions in
addition to usual care.
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Women in both intervention arms are contacted by letter
at 35 weeks' gestation. The purpose is to encourage discus-
sion of the intervention with their obstetrician and/or
midwife when they attend the clinic at 36–37 weeks to
finalise their planned method of delivery. Participation in
the study is recorded in the medical records of all women
in the trial.
Outcome measures
There are two primary outcomes:
(1) Decisional Conflict Scale (DCS) [28,29]. This is a 16
item questionnaire that measures degree of uncertainty
about which course of action to take and the main modi-
fiable factors contributing to uncertainty. Previous
research indicates that effect sizes of about 0.35 to 0.5
standard deviations can discriminate between individuals
who make a decision and those who delay or are unsure
[28]. Assuming a standard deviation of 15 points [18],
this is equivalent to differences of 5.25 to 7.5 points on
the total DCS 100 point scale.
(2) Actual mode of delivery (vaginal, elective CS, or emer-
gency CS). Unlike a previous trial [20], we are not seeking
to promote one method of delivery over another. How-
ever differences between the arms in the proportions of
different modes of delivery may have important health-
care resource implications.
There are five secondary outcomes: anxiety; [30] knowl-
edge; perception of shared decision making; satisfaction
with decision making process; proportion of women
attempting vaginal delivery.
Follow up
The primary and secondary outcomes are assessed in all
three groups at baseline, and approximately two weeks
after randomisation. The questionnaire at two weeks will
constitute a secondary follow up, and will enable suffi-
cient time for delivery of the appropriate interventions. As
part of usual care, women in the trial normally attend the
clinic at around 36–37 weeks' gestation to finalise plans
for their preferred method of delivery. Questionnaire out-
comes are measured again after this visit, and this consti-
tutes the primary follow up for this trial. Actual and
attempted mode of delivery (cross-checked with hospital
records) and satisfaction with choice are assessed by a fur-
ther postal questionnaire at approximately six to eight
weeks after giving birth.
Justification of sample size
As noted above, differences in excess of 0.35 standard
deviations have been considered as important for the total
DCS score, and differences of this magnitude are feasible
for interventions of this kind [23]. With regard to mode of
delivery, UK data indicate that about 33% of women with
one previous CS are delivered vaginally [1]. The sample
size calculation for a previous trial of written versus verbal
counselling in north America presumed a vaginal delivery
rate of 30% for a minimal intervention, and in the event
observed that 51% of women achieved vaginal delivery
for the trial groups overall [20]. A change from 30–33% to
51% corresponds to an odds ratio of about 2.1–2.4, and
this would certainly be considered as clinically important.
With two-sided 1% alpha, a total sample size of 600 pro-
vides 82–99% power to detect a standardised difference of
0.35–0.5 in total decisional conflict score between the
groups, and 84–95% power to detect odds ratios of 2.1–
2.4 in women achieving vaginal delivery. A pair-wise
alpha of 1%, corrected for multiple comparisons using
Tukey's procedure, maintains an overall study-wise alpha
of 3.4%. In order to allow for pre-term deliveries, malpre-
sentations, and losses to follow-up, we will therefore
recruit 660 women to the trial.
Statistical analysis
Data analysis will proceed according to CONSORT guide-
lines for randomised controlled trials. The first stage of the
analysis will be to use descriptive statistics to describe the
group of individuals recruited to the trial in relation to
those eligible, and to investigate comparability of the trial
arms at baseline. The primary analyses will comprise three
pair-wise intention-to-treat comparisons between deci-
sion analysis, information and usual care groups, for each
of the two primary outcomes. These comparisons will use
appropriate (that is, standard or logistic) multivariable
regression models, adjusting for maternity unit, initial
preference regarding mode of delivery, and value of the
outcome variable at baseline. Full attention will be paid to
the estimates and confidence intervals for these compari-
sons as well as the p-values, with the latter adjusted for
multiple comparisons using Tukey's procedure. Second-
ary outcomes will then be analysed in the same way, using
appropriate multivariable regression models depending
on the nature of the outcomes.
Other secondary analyses will involve investigation of the
short-term effects of the interventions using data from the
two week follow up, and the effects at 36–37' weeks gesta-
tion adjusted for both baseline and two week follow up.
Pre-planned subgroup analyses employing appropriate
interaction terms in the regression models will be used to
ascertain any differential effects of the interventions on
the two primary outcomes across the following categories
of women: previous caesarean section occurring before or
after labour; previous successful vaginal delivery; stated
preferred mode of delivery. Since the trial is powered to
detect overall differences between the groups rather than
interactions of this kind, the results of these essentially
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exploratory analyses will be presented using confidence
intervals as well as p-values, and interpreted with due cau-
tion. Finally, we will investigate the effect of differential
use of the information intervention via the internet using
descriptive statistics and appropriate comparisons with
the other groups.
Qualitative study
Qualitative research methods will be used in order to
explore aspects of the interventions and women's experi-
ences of the decision making in more depth. Specifically,
semi-structured interviews will be conducted with a sam-
ple of women from each of the intervention arms (Deci-
sion Analysis and Information), across the research sites
in Bristol and Dundee. These interviews will explore:
(1) Women's views and experiences of the intervention
and its delivery – for example, the quality and relevance of
the decision aid/information, what they felt about the risk
information presented to them, and which particular
aspects of each intervention were helpful or unhelpful.
(2) Which factors women felt had most influenced their
preferences regarding method of delivery.
(3) Whether the women had prior preferences about
method of delivery, whether/how these changed during
their pregnancy and in the case of the decision analysis,
what they felt about the method of delivery proposed by
the intervention compared to any prior preferences.
(4) Any other information sources women sought and
used to help them make a decision about method of deliv-
ery (for example, information from health professionals,
partner/family/friends, internet, media, books).
(5) Women's views and feelings about their actual
method of delivery compared with any prior preferences
and the method of delivery suggested by the intervention
(for decision analysis).
A small number of interviews may also be conducted with
women in the usual care arm of the trial to explore what
support and advice was normally provided during preg-
nancy to those who did not receive an intervention.
A sample of approximately 30 women across the two
intervention arms will be interviewed in depth to ensure a
thorough exploration of emergent themes and concepts.
Within each arm, women will be purposefully chosen to
include those with different parities/ages/socio-economic
backgrounds, and where possible different methods of
delivery/outcomes, following a maximum variation sam-
pling strategy [31]. The interviews will take place a short
time after the primary follow up, to avoid any influence of
the interview on these measures. A subset of the women
will be interviewed a second time six to eight weeks after
birth in order that they can reflect upon their decision
regarding preferred mode of delivery with the actual mode
of delivery. In addition, a small number of interviews may
take place closer in time to receipt of the intervention if
this is deemed (a) feasible given recruitment and (b)
worthwhile in terms of providing new information to that
gleaned from qualitative interviews undertaken in the
development phase of the trial.
Interviews will be conducted in the womens' homes or
other suitable setting chosen by them. A check-list of top-
ics will be used to ensure that the primary issues are cov-
ered, whilst allowing flexibility for new issues to emerge
from each interview. Interviews will be recorded on mini-
disc, fully transcribed and anonymised to protect confi-
dentiality. Transcripts will be studied in detail and a list of
common themes and concepts drawn up. Data collection
and analysis will run in parallel and the coding index
added to or refined and coded material regrouped as new
themes and categories emerge from subsequent interviews
[32]. Further analysis will employ the constant compari-
son method of grounded theory in which the textual data
is scrutinised for differences and similarities within
themes keeping in mind the context in which mention of
these themes arose in each interview [32].
In addition to the interviews with women, a small
number of focus groups with health professionals (e.g.
obstetricians, midwives) in each research site may be con-
ducted near the end of the trial, resources and time per-
mitting. Focus groups are often used in evaluations of new
services/interventions and are useful for exploring group
views, concerns and preferences (e.g. consensus or disa-
greement about an issue) [33]. They may be valuable for
exploring professionals' views about the intervention and
issues around implementation into routine practice.
Economic evaluation
The aim of the economic evaluation is to compare the
costs and benefits of the two interventions with usual
care. The analysis will be from an NHS perspective and
will be based on the costs incurred during pregnancy,
delivery and 6–8 weeks following delivery. Incremental
cost effectiveness ratios will be formed comparing (i) the
cost per point improvement on the Decisional Conflict
Scale (DCS) and (ii) the cost per extra patient able to
make a decision (represented by a 0.5 standard deviation
change on the DCS). We will also compare the average
cost of care per patient in each arm of the trial with patient
satisfaction. Differences in the cost of care of women
receiving the two interventions will be compared with
usual care from the point at which patients are ran-
domised. The analysis will include all resources under the
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control of the NHS that may differ as a result of the inter-
ventions and will include resources used by both mother
and baby. The costs identified as being of relevance are:
antenatal appointments in addition to routine appoint-
ments, including both primary and secondary care; mode
of delivery and related hospital stay for mother and baby;
follow up care for mother and baby, including primary
and secondary care appointments, outpatient appoint-
ments, inpatient stays, A&E visits, and prescribed medica-
tion.
Data on resource use will be collected principally by two
questionnaires completed by the women. The first ques-
tionnaire, completed at 36–37 weeks' gestation, will pro-
vide information on all antenatal appointments, and the
proportion of these that involved discussion about mode
of delivery. Women will be asked how often mode of
delivery was addressed at (i) routine appointments, and
(ii) appointments initiated by them to discuss mode of
delivery. A sample of 10 hand-held records from each arm
at each main centre (St Michaels, Southmead and
Ninewells, total 90) will be scrutinised to validate the
information given in response to the questionnaire. The
second questionnaire, completed six to eight weeks after
delivery, will provide information on mode of delivery
and all non-routine postnatal health service contacts and
prescriptions for both mother and baby.
The principle of opportunity cost will underlie the valua-
tion of resource use. In many cases, market rates will act as
a proxy for opportunity cost. National data sets such as the
Unit Costs of Health and Social Care [34] and the British
National Formulary [35] will be used to value primary
care consultations and prescribed medication. Secondary
care contacts will be coded according to Healthcare
Resource Group (HRG) and valued using the Department
of Health National Reference Costs [36].
Costs and outcomes will not be discounted, as the eco-
nomic evaluation will be limited to a period of 12
months. Sensitivity analysis will be conducted in areas
where there is uncertainty around assumptions about
resource use measurement and/or valuation. Variation in
resource use and the effectiveness of the intervention is
not captured by a cost-effectiveness/utility ratio. We will
use bootstrapping to address this, and construct a cost
effectiveness acceptability curve.
Discussion
Women with an uncomplicated pregnancy and expected
term delivery who have previously delivered by CS face a
choice between repeat elective CS or attempted trial of
labour. Guidelines in the UK emphasise the importance
of involving women in the decision making process and
taking account of maternal preferences and priorities, but
the type and amount of information available to women
facing this choice appears variable. The DiAMOND study
is a randomised trial that aims to inform best practice in
this area, by evaluating the effectiveness of two interven-
tions to assist decision making in terms of decision quality
and actual mode of delivery.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
Alan Montgomery, Deirdre Murphy, Ali Shaw and Sandra
Hollinghurst drafted the manuscript, with input from the
other members of the DiAMOND Study Group.
The Decision Aids for Mode Of Next Delivery (DiA-
MOND) Study Group comprises the following members:
Clare Emmett, Tom Fahey, Peter Gregor, Sandra Holling-
hurst, Claire Jones, Beverley Lovering, Alan Montgomery,
Irene Munro, Deirdre Murphy, Roshni Patel, Tim Peters,
Ian Ricketts, Anne Schlegelmilch, Ali Shaw, Kav Vedhara,
Kate Warren.
Acknowledgement
The DiAMOND study is funded by a grant from the BUPA Foundation.
References
1. Royal College of Obstetricians and Gynaecologists Clinical Effective-
ness Support Unit: The National Sentinel Caesarean Section
Audit Report. London, RCOG Press; 2001. 
2. Wagner M: Choosing caesarean section. Lancet 2000,
356:1677-1680.
3. American College of Obstetricians and Gynecologists: Evaluation of
cesarean delivery. Washington, DC, ACOG; 2000. 
4. Department of Health: Changing Childbirth. Part 1: Report of
the Expert Maternity Group. London, HMSO; 1993. 
5. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP: Risk of uter-
ine rupture during labor among women with a prior cesar-
ean delivery. NEJM 2001, 345:3-8.
6. Murphy DJ, Liebling RE, Verity L, Swingler R, Patel R: Early mater-
nal and neonatal morbidity associated with operative deliv-
ery in second stage of labour: a cohort study. Lancet 2001,
358:1203-1207.
7. Rowe-Murray HJ, Fisher JRW: Operative intervention in delivery
is associated with compromised early mother-infant interac-
tion. British Journal of Obstetrics and Gynaecology 2001, 108:1068-1075.
8. Murray SF: Relation between private health insurance and
high rates of caesarean section in Chile: qualitative and
quantitative study. BMJ 2000, 321:1501-1505.
9. Graham WJ, Hundley V, McCheyne AL, Hall MH, Gurney E, Milne J:
An investigation of women's involvement in the decision to
deliver by caesarean section. B J Obstet Gynaecol 1999,
106:213-220.
10. Minkoff H, Chervenak FA: Elective primary cesarean delivery.
NEJM 2003, 348:946-950.
11. National Collaborating Centre for Women's and Children's Health:
Caesarean Section. London, RCOG Press; 2004. 
12. Charles C, Whelan T, Gafni A: What do we mean by partnership
in making decisions about treatment? BMJ 1999, 319:780-782.
13. Coulter A: Paternalism or partnership? BMJ 1999, 319:719-720.
14. McNutt RA: Shared medical decision making - problems,
process, progress. JAMA 2004, 292:2516-2518.
15. Robinson A, Thomson R: Variability in patient preferences for
participating in medical decision making: implication for the
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pregnancy and Childbirth 2004, 4:25 http://www.biomedcentral.com/1471-2393/4/25
Page 7 of 7
(page number not for citation purposes)
use of decision support tools. Qual Health Care 2001, 10 (Suppl
I):i34-i38.
16. Montgomery AA, Fahey T: How do patients' treatment prefer-
ences compare with those of clinicians? Quality in Health Care
2001, 10 (Suppl I):i39-i43.
17. Edwards A, Elwyn G: The potential benefits of decision aids in
clinical medicine. JAMA 1999, 282:779-780.
18. O'Connor AM, Stacy D, Entwistle V, Llewellyn-Thomas HA, Rovner
D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J: Deci-
sion aids for people facing health treatment or screening
decisions. The Cochrane Database of Systematic Reviews 2003.
19. Estabrooks C, Goel V, Thiel E, Pinfold P, Sawka C, Williams I: Deci-
sion aids: are they worth it? A systematic review. Journal of
Health Services Research and Policy 2001, 6:170-182.
20. Fraser W, Maunsell E, Hodnett E, Moutquin JM: Randomized con-
trolled trial of a prenatal vaginal birth after cesarean section
education and support program. Am J Obstet Gynaecol 1997,
176:419-425.
21. Shorten A, Chamberlain M, Shorten B, Kariminia A: Making choices
for childbirth: development and testing of a decision-aid for
women who have experienced previous caesarean. Patient
Education and Counseling 2004, 52:307-313.
22. Elwyn G, Edwards A, Eccles M, Rovner D: Decision analysis in
patient care. Lancet 2001, 358:571-574.
23. Montgomery AA, Fahey T, Peters TJ: A factorial randomised con-
trolled trial of decision analysis and an information video plus
leaflet for newly diagnosed hypertensive patients. Br J Gen
Pract 2003, 53:446-453.
24. Edwards A, Elwyn G, Mulley A: Explaining risks: turning numer-
ical data into meaningful pictures. BMJ 2002, 324:827-830.
25. Detsky AS, Naglie G, Krahn MD, Redelmeier DA, Naimark D:
Primer on Medical Decision Analysis: Part 2 - Building a tree.
Med Decis Making 1997, 17:126-135.
26. Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS:
Primer on medical decision analysis: Part 3 - Estimating
probabilities and utilities. Med Decis Making 1997, 17:136-141.
27. Krahn MD, Naglie G, Naimark D, Redelmeier DA, Detsky AS:
Primer on medical decision analysis: Part 4 - Analyzing the
model and interpreting the results. Med Decis Making 1997,
17:142-151.
28. O'Connor AM: Validation of a decisional conflict scale. Med
Decis Making 1995, 15:25-30.
29. O'Connor AM: Decisional Conflict Scale. 2004 [http://decision
aid.ohri.ca/docs/Eval_Meas/Tools/DCS_Gen_Numbered.pdf].
30. Marteau TM, Bekker H: The development of a six-item short-
form of the state scale of the Spielberger State-Trait Anxi-
ety Inventory (STAI). Br J Clin Psychol 1992, 31:301-306.
31. Patton MQ: Qualitative Research and Evaluation Methods 3rd edition.
London, Sage; 2002. 
32. Hammersley M, Atkinson P: Ethnography. Principles in practice London,
Routledge; 1996:1-323. 
33. Kreuger RA: Focus Groups: A Practical Guide for Applied Research 2nd
edition. London, Sage; 1994. 
34. Personal Social Services Research Unit 2004 [http://
www.pssru.ac.uk/].
35. British National Formulary 2004 [http://www.bnf.org/bnf/].
36. Department of Health 2004 [http://www.dh.gov.uk/PolicyAnd
Guidance/OrganisationPolicy/FinanceAndPlanning/NHSReference
Costs/fs/en].
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2393/4/25/prepub
